Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 2-benzyl-3-(hexahydro-2-isoindolinylcarbonyl)propionate
2. Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate Dihydrate
3. Kad 1229
4. Kad-1229
5. Miti-glinide
6. Mitiglinide
7. S21403
1. 145525-41-3
2. Kad-1229
3. 207844-01-7
4. Kad 1229
5. Kad-1229 Calcium Hydrate
6. P5wor98g68
7. 2h-isoindole-2-butanoic Acid, Octahydro-gamma-oxo-alpha-(phenylmethyl)-, Calcium Salt, Hydrate (2:1:2), (alphas,3ar,7as)-
8. Calcium;(2s)-4-[(3as,7ar)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate
9. Kad-1229 Calcium Salt
10. Unii-p5wor98g68
11. 2-benzyl-3-(hexahydro-2-isoindolinylcarbonyl)propionate
12. S21403
13. Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate Dihydrate
14. S 21403
15. 2h-isoindole-2-butanoic Acid, Octahydro-gamma-oxo-alpha-(phenylmethyl)-, Calcium Salt, (2(s)-cis)-
16. Schembl1649332
17. Chebi:31740
18. Dtxsid90872410
19. Anhydrous Mitiglinide Calcium
20. Mitiglinide Calcium Anhydrous
21. Mfcd09955408
22. Mitiglinide Calcium [who-dd]
23. Akos015950796
24. Am84417
25. Mitiglinide Calcium Salt Anhydrous
26. As-80674
27. Calcium (s)-2-benzyl-4-((3ar,7as)-octahydro-2h-isoindol-2-yl)-4-oxobutanoate
28. M3177
29. Mitiglinide Calcium Salt Anhydrous [mi]
30. J-008096
31. Q27286263
32. (s)-2-benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric Acid Calcium Salt
33. Calcium Bis((2s)-4-[(3ar,7as)-octahydro-1h-isoindol-2-yl]-2-benzyl-4-oxobutanoate)
34. 2h-isoindole-2-butanoic Acid, Octahydro-.gamma.-oxo-.alpha.-(phenylmethyl)-, Calcium Salt (2:1), (.alpha.s,3ar,7as)-
| Molecular Weight | 668.9 g/mol |
|---|---|
| Molecular Formula | C38H48CaN2O6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | 668.3138281 g/mol |
| Monoisotopic Mass | 668.3138281 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 411 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
ABOUT THIS PAGE
77
PharmaCompass offers a list of Mitiglinide Calcium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mitiglinide Calcium manufacturer or Mitiglinide Calcium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mitiglinide Calcium manufacturer or Mitiglinide Calcium supplier.
A Mitiglinide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mitiglinide, including repackagers and relabelers. The FDA regulates Mitiglinide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mitiglinide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mitiglinide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Mitiglinide supplier is an individual or a company that provides Mitiglinide active pharmaceutical ingredient (API) or Mitiglinide finished formulations upon request. The Mitiglinide suppliers may include Mitiglinide API manufacturers, exporters, distributors and traders.
click here to find a list of Mitiglinide suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Mitiglinide DMF (Drug Master File) is a document detailing the whole manufacturing process of Mitiglinide active pharmaceutical ingredient (API) in detail. Different forms of Mitiglinide DMFs exist exist since differing nations have different regulations, such as Mitiglinide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mitiglinide DMF submitted to regulatory agencies in the US is known as a USDMF. Mitiglinide USDMF includes data on Mitiglinide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mitiglinide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mitiglinide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mitiglinide Drug Master File in Japan (Mitiglinide JDMF) empowers Mitiglinide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mitiglinide JDMF during the approval evaluation for pharmaceutical products. At the time of Mitiglinide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mitiglinide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mitiglinide Drug Master File in Korea (Mitiglinide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mitiglinide. The MFDS reviews the Mitiglinide KDMF as part of the drug registration process and uses the information provided in the Mitiglinide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mitiglinide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mitiglinide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mitiglinide suppliers with KDMF on PharmaCompass.
Mitiglinide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mitiglinide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mitiglinide GMP manufacturer or Mitiglinide GMP API supplier for your needs.
A Mitiglinide CoA (Certificate of Analysis) is a formal document that attests to Mitiglinide's compliance with Mitiglinide specifications and serves as a tool for batch-level quality control.
Mitiglinide CoA mostly includes findings from lab analyses of a specific batch. For each Mitiglinide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mitiglinide may be tested according to a variety of international standards, such as European Pharmacopoeia (Mitiglinide EP), Mitiglinide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mitiglinide USP).